6 results match your criteria: "International Institute for Restorative Reproductive Medicine[Affiliation]"
Front Reprod Health
January 2024
International Institute for Restorative Reproductive Medicine, London, United Kingdom.
Background: Low serum estradiol in early pregnancy is associated with an elevated risk of miscarriage. We sought to determine whether efforts to restore low blood estradiol via estradiol or dehydroepiandrosterone (DHEA) supplementation would reduce the risk of miscarriage as part of a multifactorial symptom-based treatment protocol.
Methods: This retrospective cohort study included women with low serum estradiol levels in early pregnancy, defined as ≤50% of reference levels by gestational age.
Hum Reprod Open
August 2022
Novant Health Triad Obstetrics & Gynecology, Winston-Salem, NC, USA.
Study Question: What is the feasibility of a prospective protocol to follow subfertile couples being treated with natural procreative technology for up to 3 years at multiple clinical sites?
Summary Answer: Overall, clinical sites had missing data for about one-third of participants, the proportion of participants responding to follow-up questionnaires during time periods when participant compensation was available (about two-thirds) was double that of time periods when participant compensation was not available (about one-third) and follow-up information was most complete for pregnancies and births (obtained from both clinics and participants).
What Is Known Already: Several retrospective single-clinic studies from Canada, Ireland and the USA, with subfertile couples receiving restorative reproductive medicine, mostly natural procreative technology, have reported adjusted cumulative live birth rates ranging from 29% to 66%, for treatment for up to 2 years, with a mean women's age of about 35 years.
Study Design Size Duration: The international Natural Procreative Technology Evaluation and Surveillance of Treatment for Subfertility (iNEST) was designed as a multicenter, prospective cohort study, to enroll subfertile couples seeking treatment for live birth, assess baseline characteristics and follow them up for up to 3 years to report diagnoses, treatments and outcomes of pregnancy and live birth.
BMC Pregnancy Childbirth
July 2021
Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Background: Restorative reproductive medicine (RRM) seeks to identify and correct underlying causes and factors contributing to infertility and reproductive dysfunction. Many components of RRM are highly suitable for primary care practice. We studied the outcomes amongst couples who received restorative reproductive medicine treatment for infertility in a primary care setting.
View Article and Find Full Text PDFFront Med (Lausanne)
July 2018
International Institute for Restorative Reproductive Medicine, London, United Kingdom.
To determine the live birth rate for patients who chose to undergo treatment with Restorative Reproductive Medicine (RRM) after previous IVF (includes ICSI). To look at birth outcomes with RRM after IVF, particularly rates of twin and higher order pregnancies, premature birth, low birth weight, and potential cost savings achieved with RRM. Two outpatient clinics in Ireland providing advanced RRM treatment of infertility.
View Article and Find Full Text PDFFront Public Health
May 2018
Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France.
Explore potential relationships between preovulatory, periovulatory, and luteal-phase characteristics in normally cycling women. Observational study. Eight European natural family planning clinics.
View Article and Find Full Text PDF